Evidence map›Paper›PMID 38128930›Full record

ArticleBMJ open2023

Establishment and validation of a prediction model for myocarditis in Chinese children below 14 years old: a protocol for a retrospective cohort study.

Lifeng Wu, Weidan Ji, Yumao Huang, Huanxuan Zeng, Jie Chen, Yueling Zou, Weiguo Lin, Yuzhan Lin

Open access · goldAbstract read
PubMed Publisher
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lifeng WuDepartment of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, Zhejiang, People's Republic of China.
Weidan JiDepartment of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, Zhejiang, People's Republic of China.
Yumao HuangPediatric Department, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, Zhejiang, People's Republic of China.
Huanxuan ZengPediatric Department, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, Zhejiang, People's Republic of China.
Jie ChenPediatric Department, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, Zhejiang, People's Republic of China.
Yueling ZouDepartment of Clinical Laboratory, Ruian Maternity and Child Care Hospital, Ruian 325200, Zhejiang, People's Republic of China.
Weiguo LinUrological Surgery, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, Zhejiang, People's Republic of China.
Yuzhan LinDepartment of Clinical Laboratory, The Third Affiliated Hospital of Wenzhou Medical University, Ruian 325200, Zhejiang, People's Republic of China 1016099047@qq.com.ORCID 0000-0001-9482-055X
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPaediatric myocarditis, a rare inflammatory disease, often presents without clear early symptoms. Although cardiac troponin I levels can aid in diagnosing myocarditis, they are not definitive indicators. Troponin I levels frequently fluctuate within and outside the reference range, potentially causing misinterpretations by clinicians. Although a negative troponin I result is valuable for excluding myocarditis, its specificity is low. Moreover, the clinical diagnosis of paediatric myocarditis is exceptionally challenging, and accurate early-stage diagnosis and treatment pose difficulties. Currently, the Dallas criteria, involving cardiac biopsy, serves as the gold standard for myocarditis diagnosis. However, this method has several drawbacks and is unsuitable for children, resulting in its limited use. METHODS AND ANALYSIS: In this study, we will employ multiple logistic regression analysis to develop a predictive model for early childhood myocarditis. This model will assess the patient's condition at onset and provide the probability of a myocarditis diagnosis. Model performance will be evaluated for accuracy and calibration, and the results will be presented through receiver operating characteristic (ROC) curves and calibration plots. Clinical decision curve analysis, in conjunction with ROC curve analysis, will be employed to determine the optimal cut-off value and calculate the net clinical benefit value for assessing clinical effectiveness. Finally, internal model validation will be conducted using bootstrapping. ETHICS AND DISSEMINATION: Approval from the Clinical Research Ethics Committee of The Third Affiliated Hospital of Wenzhou Medical University has been obtained. The research findings will be disseminated through presentations at scientific conferences and publication in peer-reviewed journals.

Indexed as

MyocarditisAdolescentChildChild, PreschoolChinaHumansRetrospective StudiesROC CurveTroponin ITroponin IACCIDENT & EMERGENCY MEDICINECardiomyopathyCommunity child health

Identifiers

PMID38128930
OpenAlexW4390055719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.